Clinical Trials on Bladder Outflow Obstruction in China

Total 886 results

Guang'anmen Hospital of China Academy of Chinese...

Recruiting

Acupuncture for Catheter-Related-Bladder Discomfort After Transurethral Surgery

Catheter-related-bladder Discomfort

China
Corcym S.r.l

Active, not recruiting

PERCEVAL S Valve Clinical Study for Chinese Registration (PERFECT)

Aortic Valve Stenosis | Aortic Valve Disease

China
Peijia Medical Technology (Suzhou) Co., Ltd.
General Hospital of Shenyang Military Region; Shanghai Zhongshan Hospital; China... and other collaborators

Completed

Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter System

Aortic Stenosis

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Impact of Home-based Cardiac Rehabilitation on Outcomes After TAVR (HBCR-TAVR)

Aortic Stenosis

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Not yet recruiting

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL） (VITAL)

Aortic Valve Stenosis | Aortic Valve Disease

China
Second Xiangya Hospital of Central South University
Xiangya Hospital of Central South University; West China Hospital; The Third... and other collaborators

Unknown

Cerebral Lesion and Neurocognitive Status Changes After TAVR (CLEVER-TAVR)

Aortic Stenosis

China
Boston Scientific Corporation
Quintiles, Inc.

Withdrawn

REPRISE China - Clinical Evaluation in China

Stenoses, Aortic Valve

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population (TORCH)

Symptomatic Aortic Stenosis

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Recruiting

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Aortic Valve Stenosis

China
Shanghai NewMed Medical Co., Ltd.
West China Hospital; The General Hospital of Northern Theater Command

Recruiting

Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study

Aortic Valve Stenosis

China
Chengdu Silara Meditech Inc.

Recruiting

To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis

Aortic Valve Stenosis

China
Shanghai NewMed Medical Co., Ltd.

Active, not recruiting

PrizValve® Transcatheter Aortic Valve Replacement Study

Aortic Valve Stenosis

China
Xijing Hospital

Recruiting

Long-term Prognosis and Valve Durability of TAVR

Aortic Valve Stenosis and Insufficiency

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Comparison of a Single Versus Double Perclose Technique for TAVR (Single)

Severe Aortic Stenosis

China
Second Affiliated Hospital, School of Medicine,...
Ningbo Medical Center Lihuili Hospital; Second Affiliated Hospital of Wenzhou... and other collaborators

Recruiting

Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly（Mrs AVS）

Valvular Heart Disease

China
Second Affiliated Hospital, School of Medicine,...

Unknown

Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population (LOTUS-CHINA)

Aortic Valve Stenosis

China
Beijing Anzhen Hospital
Beijing Municipal Health Commission

Recruiting

Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis (EPISODE)

Aortic Stenosis

China
Chinese Academy of Medical Sciences, Fuwai Hospital

Not yet recruiting

A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis

Aortic Stenosis

China
Peking University First Hospital

Recruiting

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Urinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, Bladder

China
Peijia Medical Technology (Suzhou) Co., Ltd.
General Hospital of Shenyang Military Region; West China Hospital; Second Affiliated... and other collaborators

Active, not recruiting

Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis

Aortic Stenosis

China
Guangzhou Institute of Respiratory Disease
Xiangya Hospital of Central South University; Shanghai Zhongshan Hospital; West... and other collaborators

Unknown

Multicenter Study of Impulse Oscillometry in Chinese

Chronic Obstructive Pulmonary Disease | Asthma | Healthy Subjects | Interstitial Lung Disease | Upper Airway Obstruction

China
Pan Xiangbin

Recruiting

A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis

Severe Aortic Stenosis

China
Medtronic Cardiovascular

Active, not recruiting

Evolut PRO China Clinical Study

Severe, Symptomatic Aortic Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Calcification

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Unknown

VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

Aortic Valve Stenosis

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement (SMART TAVR)

Aortic Stenosis | Transcatheter Aortic Valve Replacement | Valvular Heart Disease

China
Michael Kang-Yin Lee, MD
Asan Medical Center; Cardiovascular Clinical Research

Unknown

The Asian Pacific TAVR Multicenter Registry (AP TAVR)

Aortic Valve Stenosis

Korea, Republic of, Thailand, Malaysia, Taiwan, Japan, China, Philippines, Singapore
Venus MedTech (HangZhou) Inc.

Unknown

Safety and Performance of TAVI of Venus MedTech Aortic Valve Prosthesis (Venus-A)

Aortic Valve Stenosis | Aortic Valve Calcification

China
JC Medical, Inc.

Completed

Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation

Aortic Valve Disease

China
Medtronic Cardiac Surgery
Medtronic

Completed

PERIGON Japan Trial

Aortic Stenosis

Japan
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Recruiting

VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial

Aortic Stenosis

China
Tianjin Medical University Second Hospital
CSPC Pharmaceutical Group Limited

Unknown

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Muscle Invasive Bladder Cancer

China
Ruijin Hospital

Not yet recruiting

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Muscle-Invasive Bladder Carcinoma

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients (ASCERTAIN)

Non-muscle Invasive Bladder Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Active, not recruiting

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients (ACCRUE)

Non-muscle Invasive Bladder Cancer

China
Peking University

Withdrawn

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Invasive Bladder Cancer Stage IV

China
Beijing Pins Medical Co., Ltd
Beijing Hospital

Unknown

Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)

Refractory Overactive Bladder

China
Ruijin Hospital

Not yet recruiting

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Non-muscle-invasive Bladder Cancer

China
Qilu Hospital of Shandong University

Recruiting

Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure

Heart Failure | Aortic Stenosis, Severe

China
Zhujiang Hospital

Recruiting

Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

Urinary Bladder Cancer

China
Chinese PLA General Hospital
Beijing GeneX Health Technology Co., Ltd

Recruiting

Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

Muscle-Invasive Bladder Carcinoma

China
RenJi Hospital

Recruiting

Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer

Urothelial Carcinoma Bladder | PD-1 Inhibitor

China
Tianjin Medical University Second Hospital

Recruiting

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Muscle Invasive Bladder Cancer Urothelial Carcinoma

China
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URL

Urolithiasis | Overactive Bladder Syndrome

China
Xijing Hospital

Unknown

Transcatheter Aortic Valve Replacement With Extracorporeal Life System Support

Aortic Stenosis | Aortic Regurgitation | Heart Failure With Reduced Ejection Fraction

China
Zhujiang Hospital

Recruiting

RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Bladder Cancer | Muscle-Invasive Bladder Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Bladder Cancer

China
Third Military Medical University

Unknown

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Bladder Cancer

China
Southwest Hospital, China

Unknown

Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer

Bladder Cancer

China

Clinical Trials on Bladder Outflow Obstruction in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations